Specific conjugation of an antibody

… between natural antibody chains, such as using bromo or dibromomaleimide linkers (next-generation maleimide, NGM) (Schumacher, FF, et al. 2014, Org. Biomol. Chem. 12, 7261-69; UCL Cancer Institute), or using dibromopyrimidinedione (A. Maruani, et al., Nat. Commun., 2015, 6, 6645; M. T. Lee, et al.,